Saperstein: "Jewish values affirm the rights of women as moral decision makers, capable of making responsible choices about every aspect of their own lives."
WASHINGTON, September 29, 2000- Rabbi David Saperstein, Director of the Religious Action Center of Reform Judaism, responded to yesterday's announcement that the FDA had approved Mifepristone with the following statement:
By approving Mifepristone (known in France as RU-486), the FDA has successfully placed women's fertility back in the hands of a woman and her doctor. The reform movement of Judaism has long supported a woman's right to make moral decisions about her own life and her own body with privacy and without fear of government intrusion.
Jewish values affirm the rights of women as moral decision makers, capable of making responsible choices about every aspect of their own lives. Following the approval of mifepristone, women will now be able to use their moral and religious conscience in deciding whether or not to terminate a pregnancy within the comfort of their own homes, surrounded by their families.
The Religious Action Center of Reform Judaism is the Washington office of the Union of American Hebrew Congregations (UAHC), whose 900 congregations across North America encompass 1.5 million Reform Jews, and the Central Conference of American Rabbis (CCAR) whose membership includes over 1700 Reform rabbis.